Haoxi Health Technology announces 1-for-25 reverse share split
Reverse Share Split Announcement: Haoxi Health Technology will implement a 1-for-25 reverse share split, approved by shareholders on January 10, 2025, with trading on an adjusted basis starting January 27, 2025.
Impact on Shares: The reverse split will reduce the outstanding Class A shares from approximately 53.29 million to about 2.13 million and Class B shares from around 17.27 million to about 0.69 million, along with amendments to the company's Articles and Memorandum of Association.
Trade with 70% Backtested Accuracy
Analyst Views on HAO
About HAO
About the author

- Strategic Cooperation Agreement: Haoxi Health and Eaglepoint AI have signed a three-year strategic cooperation agreement, committing joint R&D, data, and channel resources to launch an AI health management platform, marking Haoxi's exploration of new opportunities in the AI healthcare sector.
- Innovative Technology Application: This collaboration represents the first deployment of Eaglepoint AI's Aquila data engine and multimodal model evaluation system in a health management scenario, expected to enhance the intelligence of health management and drive the development of preventive healthcare applications.
- Market Promotion Support: Haoxi Health plans to leverage its extensive marketing networks to provide user reach and commercial conversion support, while Eaglepoint AI will handle technical support, including model training and data security compliance, ensuring smooth project execution.
- Phase One Objectives: The initial phase will launch the

Haoxi Health Technology's Financial Performance: The company has a low return on capital employed (ROCE) of 4.1%, significantly below the media industry average of 9.5%, indicating underperformance despite an increase in capital employed and revenue.
Growth Strategy and Risks: Although Haoxi is reinvesting for growth, leading to higher sales, its stock has plummeted 82% over the past year, suggesting potential underlying issues, including five warning signs that investors should be aware of.

Oxford Industries Earnings Report: Oxford Industries, Inc. shares rose 15.1% in pre-market trading after reporting Q2 earnings of $1.26 per share, exceeding analyst expectations of $1.18, and raising its FY25 EPS guidance despite a revenue miss.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with YY Group Holding Limited gaining 122.9% and Vince Holding Corp rising 101%, while Robin Energy Ltd. and TOP Financial Group Limited experienced declines of 23.5% and 21.6%, respectively.
MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.
Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).
Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.

Company Announcement: Haoxi Health Technology Limited has launched a customized livestreaming agency strategy through its subsidiary, Haoxi Beijing, aimed at enhancing marketing solutions for the medical aesthetics sector in response to growing consumer demand.
Service Offerings: The new livestreaming services will provide a comprehensive approach including account setup, content planning, and post-campaign analysis, focusing on long-term brand building and improving online conversion rates for clients in the healthcare industry.

Upstart Holdings Performance: Upstart Holdings, Inc. shares surged 25.5% in pre-market trading after reporting better-than-expected fourth-quarter earnings of 26 cents per share and revenue of $218.96 million, along with optimistic FY25 revenue guidance.
Market Movements: Several stocks experienced significant pre-market gains, including Mynaric AG (+75%) and Windtree Therapeutics, Inc. (+57.3%), while others like Spire Global, Inc. saw a dramatic drop of 49.6% following a legal complaint.





